Akshara Srivastava, Sanket Koul

All stories by Akshara Srivastava, Sanket Koul

US Business Schools Eye India Partnerships
Rediff.com1 days ago

The outreach comes amid a drop in Indian student enrolments in management programmes at...

Obesity Drug Can't Be Advertised Anymore
Rediff.com1 days ago

'Any promotional activity carried out under the pretext of disease awareness,...

India Targets 200,000 Foreign Students by 2030
Rediff.com2 days ago

The government has intensified its Study in India programme and is working closely with...

'We Wanted To Create A Brand From India For The World'
Rediff.com2 Mar 2026

"There is an India that is embracing global luxury symbols and another which, as it...

Abbott Bets On Semaglutide Boom
Rediff.com28 Feb 2026

Abbott will exclusively distribute and market Extensior in the country, becoming the...

CDSCO allows immediate lab testing of drugs to speed up approvals
Rediff.com27 Feb 2026

The Centre has allowed companies to begin lab testing immediately after filing...

Gurugram Dethrones Mumbai As India's Luxury Housing Capital
Rediff.com24 Feb 2026

Gurugram has overtaken Mumbai to become India's biggest luxury housing market in 2025,...

Empty PG Seats, Missing Doctors
Rediff.com23 Feb 2026

'When young doctors see limited protection, unpredictable careers and an absence of...

Indian pharma to get stronger dose of EU mkt access
Rediff.com5 Feb 2026

The European Union's (EU's) offer to slash tariffs on 97.5 per cent of Indian chemical...

Realty to get indirect push from Budget proposals
Rediff.com3 Feb 2026

The government's Budget announcements providing tax holiday for data centres, setting...

Indra Nooyi's Career Advice For Women
Rediff.com29 Jan 2026

'Women must prioritise financial security.'

Indian Travel Gets Personal in 2026
Rediff.com28 Jan 2026

Ultra-personalisation is the new standard for Indian tourists.

Centre mandates blue strip on antimicrobial drugs to curb overuse
Rediff.com24 Jan 2026

The Union health ministry has issued draft rules to mandate a blue vertical strip on...

Dr Reddy's profit down 14% on low Lenalidomide US sales
Rediff.com22 Jan 2026

Pharma major Dr Reddy's Laboratories (DRL) reported a 14 per cent year-on-year (Y-o-Y)...

NEET-PG Cutoff Cut Sparks Merit Debate
Rediff.com22 Jan 2026

'To fill these seats, eligibility is being diluted. We are compromising merit and...

Alcoholic Beverages players identify new markets amid tax hiccups
Rediff.com21 Jan 2026

Makers of spirits, beer, and wine are working to identify new markets of growth as two...

Govt Bans Sale Of Oral Nimesulide
Rediff.com2 Jan 2026

The Union health ministry has banned the manufacture, sale and distribution of all oral...

Centre Proposes Stricter Cough Syrup Rules
Rediff.com1 Jan 2026

Following the death of 22 children due to consumption of contaminated cough syrups in...

Why non- NCR developers are flocking to Gurugram
Rediff.com30 Dec 2025

Gurugram, already established as the corporate hub of Delhi-NCR, is increasingly...

Weightloss Drugs Hit 1,000 Crore Mark
Rediff.com22 Dec 2025

'As more patients are prescribed these drugs, intolerance due to gastrointestinal and...